Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion

Clinical trial NCT01534962 · COMPLETED

Trial details

NCT number: NCT01534962
Sponsor: Menarini Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Persistent Atrial Fibrillation

Start date: 2012-01-01
Primary completion: 2013-10-01
Enrollment: 241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.